MedTrace Logo

A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation

NCT04141449 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 874

Last updated 2025-12-31

No results posted yet for this study

Summary

This study evaluates whether the Potlako+ intervention of community education, clinical provider support, and patient navigation can improve access to cancer case for patients presenting with symptoms of cancer. Half of communities will receive the Potlako+ intervention, while the other communities will continue to receive standard programs.

Conditions

Interventions

OTHER

Enhanced care

Provider education and limited patient counseling.

OTHER

Potlako intervention

Combined provider, patient, and health system intervention to expedite cancer diagnosis and care.

Sponsors & Collaborators

  • Botswana Harvard AIDS Institute Partnership

    collaborator OTHER

  • Dana-Farber Cancer Institute

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Rutgers Cancer Institute of New Jersey

    collaborator OTHER

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Scott Dryden-Peterson, MD, MSc · Brigham and Women's Hospital, Botswana Harvard AIDS Institute

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-18
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Botswana

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04141449 on ClinicalTrials.gov